Agios Pharmaceuticals Inc.

(AGIO) Trade

By |

Profile

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

Contact Information

Website: www.agios.com
Email: Renee.Leck@agios.com
Main Phone: +1 617 649-8600
Address: 88 Sidney Street
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139

Issuer Information

Exchange: NGS
CEO: David P. Schenkein
Employees: 382
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 49.37 $ -1.48 (-2.91%)
Last Price 49.37 Change $ -1.48 Change % -2.91 Tick N/A
Bid 49.29 Bid Size 100.00 Ask 49.42 Ask Size 100.00
Open 51.28 High 51.64 Low 48.55 Prev Close 50.85
Last Trade Volume 398,924 52 Wk Hi 99.82 52 Wk Low 50.02
Market Cap 2.9 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 58,178,676.00 EPS (TTM) -6.26 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 50 192
Number of Buys 17 57
Number of Sells 33 135
Net Activity 200 -20613
Last 10 Buys Shares
David Scadden 1,000
David P. Schenkein 1,000
David P. Schenkein 1,000
David P. Schenkein 1,000
John M. Maraganore 1,000
John M. Maraganore 1,000
John M. Maraganore 1,000
John M. Maraganore 1,000
Marc Tessier-Lavigne 1,000
Last 10 Sell Shares
Scott Biller 1,000
Scott Biller 1,000
Scott Biller 1,000
David P. Schenkein 1,000
David P. Schenkein 1,000
David P. Schenkein 1,000
David P. Schenkein 1,000
David P. Schenkein 1,000
David P. Schenkein 1,000
David P. Schenkein 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 125 117 115 125
Low Target Price Estimate 78 78 78 78
Mean Target Price Estimate 102.5 98 93.25 102.5
Standard Deviation 19.07 17.39 15.9 19.07
Date of Most Recent Estimate 05/31/18 05/23/18 05/07/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 3 3 4
Moderate Buy 2 2 2 2
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.67 1.67 1.57